Yüklüyor......
Epidermal Growth Factor Receptor (EGFR) Inhibitor-Induced Rash: A Consecutive Patient Series that Illustrates the Need for Rigorous Palliative Trials
PURPOSE: Rash is the most common side effect of epidermal growth factor receptor (EGFR) inhibitors and negatively impacts quality of life. This single-institution study sought to explore how rash is currently managed outside a clinical trial setting and to further characterize general clinical aspec...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Mary Ann Liebert, Inc.
2011
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3037800/ https://ncbi.nlm.nih.gov/pubmed/21226620 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/jpm.2010.0258 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|